Results showed that pro-inflammatory immunocytes (e.g., CD8 T cells and T follicular helper cells) were significantly enriched in RELN-mutated melanoma patients (Wilcoxon rank-sum test, both p < 0.05). The gene discussed is CD8A; the disease is melanoma.